Business Description
CKD Bio Corp
ISIN : KR7063160006
Compare
Compare
Traded in other countries / regions
063160.Korea IPO Date
2001-12-11Description
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.19 | |||||
| Debt-to-EBITDA | -90.11 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.22 | |||||
| Beneish M-Score | -1.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.3 | |||||
| 3-Year FCF Growth Rate | 32.5 | |||||
| 3-Year Book Growth Rate | -10 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.12 | |||||
| 9-Day RSI | 60.61 | |||||
| 14-Day RSI | 56.03 | |||||
| 6-1 Month Momentum % | 27.04 | |||||
| 12-1 Month Momentum % | -1.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 0.43 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 173.71 | |||||
| Days Sales Outstanding | 78.73 | |||||
| Days Payable | 18.2 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -21.12 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 5 | |||||
| Operating Margin % | -12.57 | |||||
| Net Margin % | -15.09 | |||||
| FCF Margin % | -11.23 | |||||
| ROE % | -17.65 | |||||
| ROA % | -7.85 | |||||
| ROIC % | -7.14 | |||||
| ROC (Joel Greenblatt) % | -7.24 | |||||
| ROCE % | -8.91 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 133.46 | |||||
| PS Ratio | 0.83 | |||||
| PB Ratio | 1.08 | |||||
| Price-to-Tangible-Book | 1.13 | |||||
| EV-to-EBIT | -14.36 | |||||
| EV-to-EBITDA | -169.1 | |||||
| EV-to-Revenue | 1.72 | |||||
| EV-to-FCF | -15.16 | |||||
| Price-to-Median-PS-Value | 0.77 | |||||
| Earnings Yield (Greenblatt) % | -6.98 | |||||
| FCF Yield % | -13.59 | |||||
| Forward Rate of Return (Yacktman) % | -52.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CKD Bio Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 160,352.779 | ||
| EPS (TTM) (â‚©) | -4410 | ||
| Beta | 1.29 | ||
| Volatility % | 27.65 | ||
| 14-Day RSI | 56.03 | ||
| 14-Day ATR (â‚©) | 630.604035 | ||
| 20-Day SMA (â‚©) | 23615 | ||
| 12-1 Month Momentum % | -1.97 | ||
| 52-Week Range (â‚©) | 19050 - 27850 | ||
| Shares Outstanding (Mil) | 5.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CKD Bio Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CKD Bio Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
CKD Bio Corp Frequently Asked Questions
What is CKD Bio Corp(XKRX:063160)'s stock price today?
The current price of XKRX:063160 is â‚©24150.00. The 52 week high of XKRX:063160 is â‚©27850.00 and 52 week low is â‚©19050.00.
When is next earnings date of CKD Bio Corp(XKRX:063160)?
The next earnings date of CKD Bio Corp(XKRX:063160) is .
Does CKD Bio Corp(XKRX:063160) pay dividends? If so, how much?
CKD Bio Corp(XKRX:063160) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers